Improving Access to Treatment for Women with Opioid Use Disorder
改善患有阿片类药物使用障碍的女性获得治疗的机会
基本信息
- 批准号:10088429
- 负责人:
- 金额:$ 26.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-15 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAgeAppointmentBiometryBirth WeightBuprenorphineCaringCharacteristicsClinicDataData SetDiagnosisDiscipline of obstetricsDrug usageEconomicsEligibility DeterminationEmploymentEnsureEvidence based treatmentFamily PracticeFemaleFetal DevelopmentFirst Pregnancy TrimesterGrowthHIV riskHealthHealth PolicyHealth Services AccessibilityHealth Services ResearchHealthcareImprove AccessIndividualInfantInsuranceInsurance CoverageLawsMeasuresMedicaidMedicaid eligibilityMedicalMedicineMethadoneMethodologyMethodsMothersNeonatalOpioid AntagonistOpioid agonistOutcomeOutpatientsPatient Self-ReportPatientsPharmaceutical PreparationsPharmacotherapyPoliciesPregnancyPregnant WomenPrivatizationProviderQualitative ResearchReportingReproducibilityResearchResourcesSourceSurveysTimeTreatment CostUninsuredUnited States Dept. of Health and Human ServicesVisitVulnerable PopulationsWait TimeWomanWorkaddictionadverse outcomecombatcriminal behaviordrug mechanismeffective therapyexperienceexperimental studyflexibilityhealth care availabilityillicit drug useimprovedimproved outcomein uterokappa opioid receptorsmu opioid receptorsopioid agonist therapyopioid epidemicopioid exposureopioid treatment programopioid useopioid use disorderoverdose deathoverdose riskprogramsrelapse riskreproductivetreatment strategywaiver
项目摘要
PROJECT SUMMARY
Over the past two decades, there has been substantial growth in opioid consumption during pregnancy,
diagnoses of opioid use disorder among pregnant women, and neonatal complications from in utero opioid
exposure. Untreated opioid use disorder among pregnant women leads to poor outcomes for the mother and
infant; however, opioid agonist treatment (OAT) for opioid use disorder is highly effective. OAT improves
treatment retention, reduces relapse risk, reduces HIV-risk, reduces criminal behavior, reduces risk of
overdose death, and improves birth weights. Further, ensuring access to OAT before pregnancy decreases the
likelihood of illicit drug use during critical times of fetal development in the first trimester. Despite evidence that
treatment is effective in mitigating adverse outcomes from opioid use disorder, evidence suggests that the vast
majority of patients in need of treatment do not receive it. We will conduct a rigorous and reproducible field
experiment of randomly-selected outpatient buprenorphine providers and opioid treatment programs in 10
states with a range of state policies. The study will include simulated female patients of reproductive age with
randomly-selected characteristics, including pregnancy status. We aim to determine whether: 1a) pregnant
women with opioid use disorder are more likely to experience difficulty accessing OAT when compared with
non-pregnant women, 1b) insurance type modifies ability to access OAT, and 2) state policies promote or
hinder access to treatment. The proposed study uses a rich array of methodologies and leverages an
experienced research team with expertise in qualitative research, health law, addiction medicine, biostatistics,
health policy, health services research, and economics. Results from this work will have immediate applicability
to state policymakers tasked with using finite resources to combat the opioid epidemic and improve outcomes
for this vulnerable population.
项目摘要
在过去的二十年里,怀孕期间阿片类药物的消费量大幅增长,
孕妇中阿片类药物使用障碍的诊断,以及宫内阿片类药物引起的新生儿并发症
exposure.孕妇中未经治疗的阿片类药物使用障碍导致母亲的不良结局,
婴儿;然而,阿片样物质激动剂治疗(OAT)对阿片样物质使用障碍非常有效。OAT改善
治疗保留,降低复发风险,降低艾滋病毒风险,减少犯罪行为,降低
过量死亡,并改善出生体重。此外,确保怀孕前获得OAT可以减少
在前三个月胎儿发育的关键时期使用非法药物的可能性。尽管有证据表明
治疗可以有效减轻阿片类药物使用障碍的不良后果,证据表明,大量
大多数需要治疗的患者没有得到治疗。我们将进行严格的和可重复的领域
随机选择的门诊丁丙诺啡提供者和阿片类药物治疗计划的实验,10
一系列国家政策。该研究将包括模拟的育龄女性患者,
随机选择的特征,包括妊娠状态。我们的目标是确定是否:1a)怀孕
阿片类药物使用障碍的女性更有可能在获得OAT方面遇到困难,
非孕妇,1b)保险类型改变获得OAT的能力,以及2)国家政策促进或
阻碍获得治疗。拟议的研究使用了丰富的方法,并利用了
经验丰富的研究团队,在定性研究,卫生法,成瘾医学,生物统计学,
卫生政策、卫生服务研究和经济学。这项工作的结果将立即适用
国家政策制定者的任务是利用有限的资源来打击阿片类药物的流行并改善结果
为这些弱势群体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen W Patrick其他文献
Hospital Quality Indicators for Opioid-Exposed Infants: Results From an Expert Consensus Panel.
阿片类药物暴露婴儿的医院质量指标:专家共识小组的结果。
- DOI:
10.1542/peds.2024-065721 - 发表时间:
2024 - 期刊:
- 影响因子:8
- 作者:
Jordan M Harrison;Bradley D Stein;Sarah F Loch;S. Lorch;Stephen W Patrick - 通讯作者:
Stephen W Patrick
The Intergenerational Impact and Trauma of Child Protective Services Referrals on Families.
儿童保护服务转介对家庭的代际影响和创伤。
- DOI:
10.1542/neo.24-11-e763 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Claudia Ocampo;Jasmyne Nelson;Lauren Harrington;Audrey Rush;Stephen W Patrick;Uchenna Anani - 通讯作者:
Uchenna Anani
A Comprehensive Approach to the Opioid Epidemic.
应对阿片类药物流行病的综合方法。
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:7.2
- 作者:
Stephen W Patrick - 通讯作者:
Stephen W Patrick
Stephen W Patrick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen W Patrick', 18)}}的其他基金
Improving outcomes for substance-affected families in the child welfare system
改善儿童福利系统中受药物影响的家庭的成果
- 批准号:
10734742 - 财政年份:2023
- 资助金额:
$ 26.68万 - 项目类别:
Leveraging Data Science to Understand Outcomes for Mothers and Children Affected by Opioids
利用数据科学了解受阿片类药物影响的母亲和儿童的结果
- 批准号:
10480929 - 财政年份:2021
- 资助金额:
$ 26.68万 - 项目类别:
Leveraging Data Science to Understand Outcomes for Mothers and Children Affected by Opioids
利用数据科学了解受阿片类药物影响的母亲和儿童的结果
- 批准号:
10674901 - 财政年份:2021
- 资助金额:
$ 26.68万 - 项目类别:
Improving Access to Treatment for Women with Opioid Use Disorder
改善患有阿片类药物使用障碍的女性获得治疗的机会
- 批准号:
10442184 - 财政年份:2021
- 资助金额:
$ 26.68万 - 项目类别:
Leveraging Data Science to Understand Outcomes for Mothers and Children Affected by Opioids
利用数据科学了解受阿片类药物影响的母亲和儿童的结果
- 批准号:
10309017 - 财政年份:2021
- 资助金额:
$ 26.68万 - 项目类别:
Neonatal Abstinence Syndrome: Risk of Drug Withdrawal in Opioid-Exposed Infants
新生儿戒断综合症:阿片类药物暴露婴儿的戒断风险
- 批准号:
9000144 - 财政年份:2015
- 资助金额:
$ 26.68万 - 项目类别:
Neonatal Abstinence Syndrome: Risk of Drug Withdrawal in Opioid-Exposed Infants
新生儿戒断综合症:阿片类药物暴露婴儿的戒断风险
- 批准号:
9250249 - 财政年份:2015
- 资助金额:
$ 26.68万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 26.68万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 26.68万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 26.68万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 26.68万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 26.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 26.68万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 26.68万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 26.68万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 26.68万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 26.68万 - 项目类别:
Miscellaneous Programs